Enforced increase of AKT signaling, either via SHIP1 inhibition or genetic activation, however, leads to a further increase in oxidative phosphorylation and to ROS levels toxic for CLL cells. The gene discussed is INPP5D; the disease is B-cell chronic lymphocytic leukemia.